Literature DB >> 24679892

Management of infertility in women over 40.

Rosalie Cabry1, Philippe Merviel2, Andre Hazout3, Stephanie Belloc4, Alain Dalleac5, Henri Copin6, Moncef Benkhalifa7.   

Abstract

Women's fertility potential is declining with age because of multiples intrinsic and extrinsic factors such as life style, oxidative stress and/or endocrine disruptors and is affecting the ability of these women to conceive naturally. This declining fertility potential and the late age of motherhood is increasing significantly the number of patients consulting infertility specialists. Different strategies of investigation and management are proposed to patients over 40 in order to overcome their infertility and improve the live birth rate in these patients. Intra Uterine Insemination (IUI) in women over 40 is associated with a low rate of ongoing pregnancy and IUI should not therefore be offered always as the first line of treatment. When the predictive factors are positive IVF/ICSI seem to be good alternatives until 43 years of age. Customized ovarian stimulation and flexible laboratory methods such as in vitro maturation (IVM), preimplantation genetic diagnosis (PGD), embryo vitrification and transfer after thawing in subsequent natural or artificial cycles can improve the success rate of ART in patients over 40. Meanwhile, oocyte and embryos donation remain good options for patient over 40 with a bad prognosis and can lead to successful ongoing pregnancies until 45 years of age. Ovarian tissue cryopreservation, oocyte vitrification at the germinal vesicle (GV) stage or metaphase II stage present a breakthrough for fertility preservation but the ideal age for starting fertility preservation is still debated as well as the minimum number of oocytes to be vitrified in order to optimize the chances of pregnancy when needed at an older age. This manuscript reports the results of our own experience from patients older than 40 in the light of the published data and discusses the different therapeutic alternatives which can be proposed to patients over 40 consulting ART centres.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technology; Female over 40; Fertility potential

Mesh:

Year:  2014        PMID: 24679892     DOI: 10.1016/j.maturitas.2014.02.014

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  15 in total

1.  One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date.

Authors:  Vinay Gunnala; Mohamad Irani; Alexis Melnick; Zev Rosenwaks; Steven Spandorfer
Journal:  J Assist Reprod Genet       Date:  2017-11-16       Impact factor: 3.412

Review 2.  Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.

Authors:  Carleigh B Nesbit; Misty Blanchette-Porter; Navid Esfandiari
Journal:  J Assist Reprod Genet       Date:  2022-06-22       Impact factor: 3.357

3.  Twin pregnancy after intracytoplasmic sperm injection in woman aged 49 using autologous oocytes by mild ovarian stimulation: a case report.

Authors:  Guimin Yan; Xiaodong Xie; Yanqiu Wang; Lihong Shi; Wei Zhou; Yingling Liu; Xiaowen Tong; Yazhong Ji
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Twin pregnancy after intracytoplasmic sperm injection in woman aged 49 using autologous oocytes by mild ovarian stimulation: a case report.

Authors:  Guimin Yan; Xiaodong Xie; Yanqiu Wang; Lihong Shi; Wei Zhou; Yingling Liu; Xiaowen Tong; Yazhong Ji
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Infertile men older than 40 years are at higher risk of sperm DNA damage.

Authors:  Saad Alshahrani; Ashok Agarwal; Mourad Assidi; Adel M Abuzenadah; Damayanthi Durairajanayagam; Ahmet Ayaz; Rakesh Sharma; Edmund Sabanegh
Journal:  Reprod Biol Endocrinol       Date:  2014-11-20       Impact factor: 5.211

6.  Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.

Authors:  Massimo Tartagni; Maria V Cicinelli; Domenico Baldini; Mario V Tartagni; Hala Alrasheed; Maria A DeSalvia; Giuseppe Loverro; Monica Montagnani
Journal:  Reprod Biol Endocrinol       Date:  2015-03-09       Impact factor: 5.211

Review 7.  The Bologna criteria for poor ovarian response: a contemporary critical appraisal.

Authors:  Johnny S Younis; Moshe Ben-Ami; Izhar Ben-Shlomo
Journal:  J Ovarian Res       Date:  2015-11-17       Impact factor: 4.234

8.  Advanced maternal age causes adverse programming of mouse blastocysts leading to altered growth and impaired cardiometabolic health in post-natal life.

Authors:  M A Velazquez; C G C Smith; N R Smyth; C Osmond; T P Fleming
Journal:  Hum Reprod       Date:  2016-07-07       Impact factor: 6.918

9.  Clinical analyses of successful and previously failed intracytoplasmic sperm injection cycle parameters in patients with poor ovarian reserve.

Authors:  Tayfun Kutlu; Enis Özkaya; Pınar Kumru; Habibe Ayvacı; Belgin Devranoğlu; İlhan Sanverdi; Yavuz Şahin; Beyhan Sağlam; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2017-03-15

10.  C-phycocyanin protects against low fertility by inhibiting reactive oxygen species in aging mice.

Authors:  Yan-Jiao Li; Zhe Han; Lei Ge; Cheng-Jie Zhou; Yue-Fang Zhao; Dong-Hui Wang; Jing Ren; Xin-Xin Niu; Cheng-Guang Liang
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.